Keratin 17 Activators

Retinoic Acid interacts with nuclear receptors to regulate gene transcription, potentially leading to heightened expression of keratins. Similarly, 1,25-Dihydroxyvitamin D3 binds its specific receptor, triggering gene expression changes that can include keratin upregulation. Growth factors such as Epidermal Growth Factor (EGF) engage with cell surface receptors, setting off a cascade of intracellular signaling events through the MAPK and PI3K/AKT pathways, which can culminate in the upregulation of keratin genes. Tumor necrosis factor (TNF-α), along with cytokines like Interleukin-1 (IL-1) and Interferon Gamma (IFN-γ), activate NF-κB and other related pathways, potentially leading to the modulation of keratin expression, including that of KRT17.

ALK5 Inhibitor II is known for its involvement in cellular differentiation and proliferation, and it may also affect keratin expression by directing changes in the cellular phenotype that involve keratin remodeling. Forskolin, through its elevation of cAMP levels, can affect protein kinase A activity and its downstream targets, potentially leading to changes in keratin regulation. Lithium Chloride activates the Wnt/β-catenin pathway, which has been implicated in the regulation of genes, including those encoding keratins. Methyl Jasmonate influences cellular signaling pathways and could affect keratin expression. Dexamethasone binds to glucocorticoid receptors, altering gene expression profiles that can include keratins. Phorbol 12-Myristate 13-Acetate (PMA) activates protein kinase C, which might lead to alterations in keratin expression, reflecting the complex interplay between cellular signaling and structural protein regulation.